EGFR is expressed in 75% of human corticotroph adenomas (69, 71), and gefitinib treatment of human primary pituitary corticotroph tumor cultures reduced POMC mRNA and reversed features of hypercortisolemia (71). The gene discussed is EGFR; the disease is neoplasm.